Pathophysiologic Basis and Clinical Rationale for Early Ambulatory Treatment for COVID-19 and Update on Vaccine Safety, P.A. McCullough

Pathophysiologic Basis and Clinical Rationale for Early Ambulatory Treatment for COVID-19 and Update on Vaccine Safety

References:
P.A. McCullough, R.J.Kelly, G. Ruocco, E. Lerma, J. Tumlin, K.R.Wheelan, N. Katz, N.E. Lepor, K. Vijay, H. Carter, B. Singh, S.P. McCullough, B.K. Bhambi, A. Palazzuoli, G.M. De Ferrari, G.P.Milligan, T. Safder, K.M. Tecson, H.A. Risch: "Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection", The American Journal of Medicine 134 (2020), 16-22
https://doi.org/10.1016/j.amjmed.2020.07.003

P.A. McCullough. "Innovative Early Sequenced Multidrug Therapy for Sars-Cov-2 (Covid-19) Infection to Reduce Hospitalization and Death", International Journal of Medical Science and Clinical Invention 7 (2020), 5139-5150
https://doi.org/10.18535/ijmsci/v7i12.02

P.A. McCullough, P.E. Alexander, R. Armstrong, C. Arvinte, A.F. Bain, R.P. Bartlett, R.L. Berkowitz, A.C. Berry, T.J. Borody, J.H. Brewer, A.M. Brufsky, T. Clarke, R. Derwand, A. Eck, J. Eck, R.A. Eisner, G.C. Fareed, A. Farella, S.N.S. Fonseca, C.E. Geyer, Jr., R.S. Gonnering, K.E. Graves, K.B.V. Gross, S. Hazan, K.S. Held, H. Thomas Hight, S. Immanuel, M.M. Jacobs, J.A. Ladapo, L.H. Lee, J. Littell, I. Lozano, H.S. Mangat, B. Marble, J.E. McKinnon, L.D. Merritt, J.M. Orient, R. Oskoui, D.C. Pompan, B.C. Procter, C. Prodromos, J.C. Rajter, J-J. Rajter, C. V.S. Ram, S.S. Rios, H.A. Risch, M.J.A. Robb, M. Rutherford, M. Scholz, M.M. Singleton, J.A. Tumlin, B.M. Tyson, R.G. Urso, K. Victory, E.L. Vliet, C.M. Wax, A.G. Wolkoff, V. Wooll, V. Zelenko. "Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)", Reviews in Cardiovascular Medicine 21 (4) (2020), 517-530
https://rcm.imrpress.com/EN/Y2020/V21/I4/517

Mirrored from:
https://www.youtube.com/watch?v=e6CA3q0qZdU

Help Dr Peter McCullough with legal, IT, and travel costs. Donate here:
https://givesendgo.com/G2DR5